Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Finished Goods (2016 - 2025)

Historic Finished Goods for Bio-Techne (TECH) over the last 15 years, with Q4 2025 value amounting to $114.8 million.

  • Bio-Techne's Finished Goods rose 425.68% to $114.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $114.8 million, marking a year-over-year increase of 425.68%. This contributed to the annual value of $106.2 million for FY2025, which is 10.94% up from last year.
  • Bio-Techne's Finished Goods amounted to $114.8 million in Q4 2025, which was up 425.68% from $114.9 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Finished Goods peaked at $114.9 million during Q3 2025, and registered a low of $66.9 million during Q2 2022.
  • For the 5-year period, Bio-Techne's Finished Goods averaged around $97.6 million, with its median value being $105.2 million (2024).
  • In the last 5 years, Bio-Techne's Finished Goods dropped by 24.59% in 2022 and then soared by 3813.84% in 2023.
  • Bio-Techne's Finished Goods (Quarter) stood at $67.1 million in 2021, then rose by 20.03% to $80.5 million in 2022, then rose by 27.76% to $102.9 million in 2023, then rose by 7.04% to $110.2 million in 2024, then grew by 4.26% to $114.8 million in 2025.
  • Its last three reported values are $114.8 million in Q4 2025, $114.9 million for Q3 2025, and $106.2 million during Q2 2025.